News Releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
- Feb 11, 2019Transaction adds an additional potential 2019 product launch to Eton’s pipeline
DEER PARK, Ill., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...
- Feb 07, 2019
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release fourth quarter 2018 financial and operating results on Tuesday, March 5, 2019 after the close...
- Feb 06, 2019
MIAMI, Feb. 06, 2019 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company developing novel medicines for the prostate cancer continuum of care and...
- Feb 06, 2019
FARMINGDALE, N.Y., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that...
- Feb 04, 2019— Nine Abstracts Featured, Including Data on Longer-Term AR101 Efficacy and Safety and PALISADE Accidental Exposures —
BRISBANE, Calif.--(BUSINESS WIRE)--Feb. 4, 2019-- Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies,...
- Feb 04, 2019Feb. 4 event will include meet-and-greets with Dallas Mavericks players, Mavs ManiAACs, dancers, and families will learn more about the latest dental technologies, including laser treatments
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, the Dallas Mavericks and TeamSmile, the nation's premier advocacy group that supports life-changing dental care for underserved...
- Jan 29, 2019On the heels of a successful co-promotion during the recent Greater New York Dental Meeting, the two companies will offer exclusive deals and product samples for complimentary product lines at the Yankee Dental Congress and Chicago Midwinter Meeting
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today a joint product promotion with Hu-Friedy, the global leader in the manufacturing of dental instruments, at two...
- Jan 25, 2019
TORONTO--(BUSINESS WIRE)-- Acerus Pharmaceuticals Corporation (TSX: ASP) (“Acerus” or the “Company”) is today advising that it has received a Notice of Deficiency-Withdrawal Letter...
- Jan 24, 2019New Drug Application expected to be filed in 2019
DEER PARK, Ill., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...
- Jan 22, 2019–Open-Label Phase 1b/2 Clinical Trial Results Expected by Year-End– — Drug Addresses Significant Unmet Medical Need —
MIAMI, Jan. 22, 2019 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company, today announced that it has initiated and enrolled the first patient in a...